Project Grant R21AI190857
Award Date
6/11/25
Completion Date
5/31/27
Dollars Obligated
$416K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $800,200 to study the mechanisms of interferon-gamma (IFN-γ)-independent T cell and B cell-mediated protection against tuberculosis (TB) in humans. The research aims to elucidate the IFN-γ-independent T cell response and characterize the B cell, antibody, and T follicular helper (Tfh) cell responses in...
This federal Project Grant award of $586,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research program supports research to investigate how distinct age-associated B cell subsets can protect the aged from influenza. The project aims to determine the potential of different age-associated B cell subsets to respond to influenza infection and generate antibody-secreting cells, B cell memory, and long-lived...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $176,152 to Rutgers, The State University of New Jersey to study host-pathogen interactions and carbon processing in glycerol kinase deficient Mycobacterium tuberculosis. The goal is to identify new drug targets to improve the efficacy of tuberculosis (TB) treatment, as drug-tolerant TB strains are a major challenge....
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to develop a new tool for measuring functional B cell immunity against influenza infection. The $811,009 award, effective November 13, 2024 through October 31, 2029, aims to: 1) enhance and optimize a microfluidic device to capture and separate peripheral B cells based on their B cell receptor...
This $806,693 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research at New York University School of Medicine to elucidate the mechanisms governing lymphangiogenesis (growth of lymphatic vessels) in acute and homeostatic inflammation, and determine the functional consequences of lymphatic encapsulation of B cell follicles on germinal center dynamics. The research aims to resolve the...
This federal Project Grant award of $606,501 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the role of the BAF chromatin remodeling complex in regulating germinal center B cell responses. The overarching goal is to provide comprehensive mechanistic insights into how the ARID1A-dependent canonical BAF complex (ARID1A-cBAF) establishes the germinal center transcriptional...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant valued at $718,758 to the Texas Biomedical Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is focused on evaluating the use of IL-21-IgFc fusion protein as a host-directed immunotherapy to improve immune reconstitution and reduce the risk of latent tuberculosis (TB) reactivation in Mycobacterium tuberculosis (MTB) and simian immunodeficiency virus (SIV)...
This $246,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research supports research to investigate the role of lung repair and regeneration pathways in tuberculosis (TB). The award aims to determine the functional role of the bone morphogenetic protein (BMP) signaling pathway in TB control and reactivation, as well as characterize the cellular mechanisms of BMP pathway activation during TB...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on understanding the molecular basis for differences in vaccine efficacy between various sub-strains of the Bacillus Calmette-Guérin (BCG) tuberculosis vaccine. The total funding amount is $749,192, awarded on November 22, 2024, with a completion date of October 31, 2029. The key objectives of this research project...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $837,497 to Yale University over a 5-year period ending April 30, 2030. The project aims to elucidate the role of the PI3K-gamma enzyme in regulating the antibody response, with a focus on understanding the molecular mechanisms by which B cells utilize PI3K-gamma signaling to differentiate into antibody-secreting...